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Background: Chronic refractory hypotension is a rare but significant mortality risk in renal failure patients. Such
aberrant physiology usually deems patient unfit for renal transplant surgery. Exercise stimulates the mechano-
chemoreceptors in the skeletal muscle thereby modulating the sympathetic effects on blood pressure regulation. The
haemodynamic response to dynamic exercise in such patients has not been previously investigated. We present a case
with severe chronic hypotension who underwent exercise testing before and after renal transplantation, with marked
differences in blood pressure response to exercise.
Case Presentation: A 40-year old haemodialysis-dependent patient with a 2 year history of refractory hypotension
(≤80/50 mmHg) was referred for living donor renal transplantation at our tertiary centre. Each dialysis session was often
less than 2 h and 30 min due to symptomatic hypotension. As part of the cardiovascular assessment, she underwent
haemodynamic evaluation with cardiopulmonary exercise testing. Blood pressure normalized during unloaded
pedalling but was exaggerated at maximal workload whereby it rose from 82/50 mmHg to a peak of 201/
120 mmHg. Transthoracic echocardiography, tonometric measure of central vascular compliance and myocar-
dial perfusion scan were normal. She subsequently underwent an antibody-incompatible renal transplantation
and was vasopressor reliant for 14 days during the post-operative period. Eight weeks following transplant,
resting blood pressure was normal and a physiological exercise-haemodynamic response was observed dur-
ing a
repeat cardiopulmonary exercise testing.
Conclusion: This case highlights the potential therapeutic role of unloaded leg cycling exercise during dialysis session
to correct chronic hypotension, allowing patients to have greater tolerance to fluid shift. It also adds to existing
evidence that sympathetic dysfunction is reversible with renal transplant. Furthermore chronic hypotension with
preserved exercise-haemodynamic response and cardiovascular reserve should not preclude these patients from renal
transplant surgery.
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Chronic refractory hypotension (inter-dialytic systolic
blood pressure, SBP <100 mmHg) in long-term dialysis pa-
tients is a rare but serious problem. Sustained hypotension
between dialysis sessions occurs in 5–10 % and is associ-
ated with poor outcomes, including increased mortality
[1]. These patients are often deemed unfit for surgery
including renal transplant.
Proposed mechanisms focus on inadequate cardiovascu-
lar response because of autonomic dysfunction and
reduced vascular response to vasopressors [2, 3]. These
patients have high levels of circulating noradrenaline but
reduced alpha-adrenoreceptor density, which is associated
with a blunted pressor response [2]. Reduced sympathetic
nerve discharge due to the loss of renal afferent nerve end-
ings is a major causative factor for persistent hypotension
in anephric patients [4]. Post-dialysis reduced plasma con-
centrations of chromogranin A (a protein co-released with
cathecholamines) are seen compared to normotensive
patients, consistent with blunted sympathetic response [5].
Interleukin-6 and C-reactive protein (CRP) levels have
been shown to correlate with mean arterial pressure in
hypotensive patients during haemodialysis suggesting an
inflammatory role [6].
Current treatment strategies rely on intravascular vol-
ume monitoring, alterations in dialysate composition and
vasoconstricting drugs [3, 7]. However, there is no defini-
tive management presently. Midodrine and vasopressin
therapy have been shown to be effective only in some pa-
tients [7]. The most promising technologies are those cap-
able of real-time monitoring of dialysis composition,
ultrafiltration rate and temperature and adjust accordingly
minute by minute [3]. The levels of sodium, potassium,
calcium, bicarbonate and magnesium have all been shown
to alter the risk of hypotension during dialysis [7]. Sodium
levels appear to have the most significant effect; dialysates
with higher sodium concentrations may reduce rates of
hypotension during dialysis [8]. Ultrafiltration is associated
with a rise in core body temperature secondary to complex
autonomic mechanisms; the central response to this is
vasodilation. Thus, cooling dialysate from 37 °C to 35° has
been shown to maintain intra-dialytic blood pressure (BP)
in a number of patients [9].
Although the proposed mechanisms above highlight
the hyporesponsiveness of the efferent or afferent sym-
pathetic receptors in causing refractory hypotension, it
remains uncertain if stimulation of the skeletal chemo-
sensitive or mechano-receptors through dynamic exer-
cise could modulate haemodynamics in these patients.
We present a case of severe chronic hypotension who
underwent dynamic exercise testing before and after
renal transplantation, with marked differences in blood
pressure response to exercise.Case report
A 40-year old female haemodialysis-dependent patient
had a 2 year history of chronic refractory severe
hypotension (≤80/50 mmHg). Previous treatment with
α1-adrenergic agonist, mineralocorticoid analog and
optimization of dialysate composition with sodium con-
centration >140 mmol/L and use of bicarbonate buffers
had been non-effective. Aetiology of renal failure was
reflux nephropathy. She had right native nephrectomy
and left native pyeloplasty performed 21 years previ-
ously. She received a cadaveric renal graft 13 years ago
which failed 9 years later because of chronic allograft
nephropathy. The failed graft was removed 3 years previ-
ously due to recurrent sepsis. She had been anuric for
the last 4 years. There was no history of diabetes, heart
failure or ischemic heart disease. She had been on
hemodialysis for 6 years following failed peritoneal dialy-
sis. Dialysis adequacy during the 6 months prior to
transplant was recorded with urea reduction rate of
75 % and Kt/V (measure of clearance per dialysis
factored for patient size) of 1.6.
Evaluation prior to renal transplant and 8 weeks
following transplant
Computed tomography scan revealed a grossly atrophic
native left kidney. Transthoracic echocardiography showed
normal valves, pericardium and ejection fraction was 62 %.
Measures of central vascular stiffness were normal with
carotid-femoral pulse wave velocity (PWV) of 5.9 m/s
(reference range: 4.5–9.6 m/s) and augmentation index
corrected to heart rate (AIx75) of 21 % (reference range:
19–24 %). Myocardial perfusion scan was normal. On
maximal cardiopulmonary exercise testing (CPET) [10],
oxygen consumption at peak exercise (VO2peak) was
18 ml/min/kg (73 % of predicted VO2peak) (Table 1). Fol-
lowing 3 min rest, pedaling without load (freewheel stage
of exercise) produced a 50 % increment in BP from base-
line. An exaggerated rise in SBP and diastolic BP (DBP)
was recorded at maximal work load, whereby BP rose
from 82/50 mmHg to a peak of 201/120 mmHg (ΔSBP/
ΔDBP = 119/70 mmHg). At this point, the patient
abruptly ceased pedaling and a rapid decline in BP to
baseline level was documented (Fig. 1).
The patient proceeded to have an HLA antibody-
incompatible kidney transplant. Immunosuppression
consisted of mycophenolate mofetil, tacrolimus and
prednisolone. A single dose of 500 mg methylpredniso-
lone intra-operatively and basiliximab 20 mg were given
at days 0 and 4. Pre-operatively she underwent seven
sessions of HLA antibody removal therapy [11, 12] with
cryofiltration, with a further two sessions (day 1 and 2)
following surgery and one session of double filtration
plasmapheresis on day 3. During the intraoperative period,
her BP was supported by infusion of metaraminol. Post-
Table 1 Characteristics before and after kidney transplant














LV ejection fraction, % 62.3 63.3 ≥50
E/mean e' 8.0 9.9 ≤10
Vascular
Aortic PWV (m/s) 5.9 6.4 4.5–9.6
AIx75 (%) 21 28 19–24
Biochemical
Creatinine, μmol/l 446 139 50–90




Albumin, g/l 44 44 35–50
Cortisol, nmol/l 433 356 150–720
Aldosterone, pmol/l
Pre-exercise 515 372 28–445
Post-exercise 1342 - 28–445
Renin, mU/l
Pre-exercise <9.0 9.0 9.8–23.8
Post-exercise <9.0 - 9.8–23.8
Cardiopulmonary exercise test
FEV1/FVC, % 78 77 75–80










Endurance time, min 10.4 11.3 -
RER at peak exercise 1.4 1.3 -
HR at rest, beat/min 82 73 -
HR at peak exercise,
beat/min
141 142 -
LV left ventricular, E/mean e' ratio of early transmitral flow velocity to annular
mitral velocity (averaged of septal and lateral), PWV pulse wave velocity, AIx75
augmentation index corrected to heart rate, FEV1/FVC, ratio of forced
expiratory volume in 1 s to full vital capacity, VO2peak oxygen consumption at
peak exercise, VO2AT oxygen consumption at the point of anaerobic threshold,
RER respiratory exchange ratio of CO2 production to O2 consumption, HR
heart rate
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which point the creatinine was 133 μmol/l (eGFR 41 ml/
min/1.73 m2).
Eight weeks following transplantation, her resting BP
without anti-hypertensive agent was 124/82 mmHg.
Graft function was moderate with eGFR 39 ml/min/
1.73 m2. On repeat CPET, SBP rose uniformly but DBP
did not rise from baseline (ΔSBP/ΔDBP = 19/-13 mmHg)
(Fig. 1). VO2peak was comparable to the pre-transplant
measure but there was improvement in the anaerobic
threshold following transplant (VO2AT, 48 vs. 41 % of
predicted VO2peak). Cortisol, renin and aldosterone
levels at rest were (pre- vs. post-transplant) 433 vs.
356 nmol/l, <9 vs. 9 mU/l and 515 vs. 372 pmol/l,
respectively (Table 1).
Discussion
To our knowledge this is the first human case study
demonstrating an exaggerated BP response to dynamic
exercise using CPET in a patient with end-stage renal
disease (ESRD) and refractory chronic hypotension.
Exercise increases sympathetic and reduces parasympa-
thetic activity resulting in augmented cardiac contractil-
ity, stoke volume, heart rate and blood pressure [13].
This adaptive response known as the exercise pressor
reflex (EPR) is regulated by mechano- and chemorecep-
tors in the skeletal muscle [14]. Despite the chronicity of
profound hypotension, the patient developed augmenta-
tion of BP and tachycardia during the warm-up unloaded
phase of exercise. Furthermore, following an abrupt
discontinuation of pedaling at maximal stress, a rapid
decline in BP was documented. Thus, EPR in the absence
of work load appears to be driven by stimulation of the
muscle stretch receptors that creates an afferent sympa-
thetic stimulus [14].
In healthy individuals, a regulated increase in cardiac
output and a reduction in peripheral vascular resistance
(PVR) during exercise produce a rise in SBP while keep-
ing the DBP stable [13], similar to the haemodynamic
profile observed at post-transplant in our case. Skeletal
muscle PVR is tightly regulated between vasoconstrict-
ing and dilating signals to produce a precise functional
response from the vascular endothelium allowing max-
imal muscular work [15]. The exaggerated SBP and DBP
at maximal workload but low BP during non-pedaling
rest documented prior to transplant could be generated
by over-compensatory mechanoreceptor activation in
response to hyporesponsive chemoreceptors in the skel-
etal muscle beds [16]. The latter has been observed in
ESRD patients whereby uraemia and inflammatory cyto-
kines are thought to downregulate or cause altered
signal transduction in the receptors [1, 17]. Additionally,
the absence of renin in our patient prior to transplant sug-
gested not only loss of crucial haemodynamic regulatory
Fig. 1 Haemodynamic profile (a) during a typical haemodialysis session lasting≤ 2 h and (b) with cardiopulmonary exercise before renal
transplant (dotted line) and 8 weeks following transplant (grey line). SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate
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[18] but also renal afferent signaling. This along with an
inflated sympathetic response from the enhanced activity
of the skeletal mechanoreceptors further impedes the abil-
ity of skeletal vasodilatation during exercise. When cardiac
output is not balanced by increased compliance from
peripheral vasculature, the result is sharp rise in BP [13].
ESRD patients are known to have profound exercise
intolerance [9] due to abnormal haemodynamic and
autonomic responses impairing oxygen delivery to skel-
etal muscle [14]. Following transplantation, exercise
tolerance of the patient improved as demonstrated by
the increased endurance time, maximal workload and
anaerobic threshold. This suggests restored autonomic
function and improved oxygen delivery to muscles due
to regulated vasodilatation in exercising skeletal muscle
capillary beds. Normalization of BP with transplant was
also associated with presence of plasma renin and a
reduction in pre-exercise levels of stress hormones
(aldosterone and cortisol).
Limitations
Unfortunately a post-exercise aldosterone level was not
obtained due to an analysis problem but we propose this
level would have been much lower than that seen before
transplant. Therefore, restitution of renal-derived regula-
tory hormones and renal afferent nerves with a trans-
plant were the likely explanation for the correction of
chronic hypotension and EPR. Data on muscle mass orstrength were not collected in this study. However, exer-
cise measurements of gases indicated the lack of major
skeletal pathology. Despite being hypotensive at rest, this
patient was able to complete a maximal exercise testing
beyond the point of anaerobic metabolism, achieving an
endurance time of 10.4 min (if less than 8 min, muscular
deconditioning could play a role). Also, at peak exercise,
the objective measure of volitional fatigue determined by
the respiratory exchange ratio (RER = ratio of CO2 out-
put to O2 uptake) was 1.4 whereby a sustained RER of
1.1 is a minimum target level for a maximal test.
Although the health related quality of life data was not
available, we recognized that the physiological BP response,
dialysis independence and increased exercise capacity
following transplant could all lead to an improved overall
quality of life.Conclusion
Our findings suggest there may be a therapeutic role of
dynamic exercise in ESRD to correct chronic hypotension,
at least temporarily. Unloaded cycling exercise during
dialysis sessions may allow these patients to have greater
tolerance to fluid shift. Our results add to existing
evidence that sympathetic dysfunction is reversible with
renal transplant [1]. Furthermore chronic hypotension
with preserved exercise-haemodynamic response and
cardiovascular reserve should not preclude these patients
from transplant surgery.
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